// App-Quantinova.ai

TCT-484 : Impact of Second Generation Drug-Eluting Stents on the Occurrence of Late and Very Late Stent Thrombosis - A Subanalysis of the Large, Prospective DESIRE (Drug-Eluting Stent In the REal World) Registry

Researchers

Presenter

  • Ricardo A. Costa

Principal Investigators

  • Lucas P. Damiani

Medical Centers

  • ICU, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Multi-vessel disease

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Umirolimus

  • ZoMaxx

  • Everolimus

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved